Is biotech really up?

• Position: Triangle

A report that shows North Carolina's publicly traded biotechnology companies increased profits more than any other state's might be overstating it--at least where the Triangle is concerned. The study says net income of Tar Heel biotechs grew 237% between 2009 and 2010. But New York-based Ernst & Young LLP examined only "selected" businesses and did...